Inflammation Research and Drug Development | Charles River

inflammation 

 
 

At Charles River, we can appreciate how complex your inflammatory disease research can be. We have the experience and expertise to help advance your understanding of the cellular processes involved and identify therapeutic targets and markers of disease to develop new approaches to diagnosis, prevention and treatment.

Inflammation is a natural biological response to irritation or injury that promotes healing and repair. However, inappropriately triggered or incompletely controlled inflammatory responses are a major cause of ill health, impaired quality of life and morbidity.  Our research models, discovery and imaging services, preclinical pharmacology models, safety assessment programs, early-phase clinical trials and full laboratory support services enable us to expertly and efficiently support your research in the area of inflammation.


Charles River and WuXi AppTec to Combine

For more information please call:

(Country Code)+800.3195.3430
askcharlesriver@crl.com

view all
With expertise in the key therapeutic areas of oncology and inflammation, MIR Preclinical Services offers non-GLP preclinical efficacy testing services supported by extensive in vivo imaging capabilities.

News & Events

view all
avr. 26 - Charles River / WuXi Customer Inf...
avr. 26 - Charles River / WuXi Investor Inf...
sept. 03-sept. 04 - Asahikawa, Hokkaido, Japan - Japanese Association for Experimental ...
août 24-août 27 - South Carolina, USA - Charles River LAL Workshop
view all
Clinical Pathology Analyst Tranent, Scotl...
Health & Safety Officer Tranent, Scotland

Charles River Laboratories, Inc.